Dryja, Ted (2016) Early Insight Into Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology, 134 (11). pp. 1281-1282. ISSN 2168-6173

Abstract

This is a 1025-word invited editorial that comments on a paper to be published in the JAMA Ophthalmology journal. I comment on the main point of the article and how it is relevant to our understanding of neovascular age-related macular degeneration (AMD). I don't mention any drugs in the NIBR pipeline or anywhere in Novartis or any projects in NIBR or Novartis.

Item Type:	Article
Additional Information:	Unmapped bibliographic data: LA - English [Field not mapped to EPrints] ST - Early Insight Into Neovascular Age-Related Macular Degeneration [Field not mapped to EPrints] AU - Dryja, T. P. [Field not mapped to EPrints] J2 - JAMA Ophthalmol [Field not mapped to EPrints] AD - Dryja,Thaddeus P. Novartis Institutes for Biomedical Research, Cambridge, Massachusetts2Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston. [Field not mapped to EPrints] M3 - Journal article [Field not mapped to EPrints] DB - MEDLINE [Field not mapped to EPrints] DP - Ovid Technologies [Field not mapped to EPrints] AN - 27657333 [Field not mapped to EPrints]
Keywords:	age-related macular degeneration neovascularization histology
Date Deposited:	30 Nov 2016 00:45
Last Modified:	30 Nov 2016 00:45
URI:	https://oak.novartis.com/id/eprint/29831